×
About 2,183 results

ALLMedicine™ Emergency Contraception Center

Research & Reviews  535 results

Contextual factors associated with contraceptive utilization and unmet need among sexua...
https://doi.org/10.1371/journal.pone.0270516
PloS One; Nemser B, Addofoh N

Jul 1st, 2022 - Unmarried women who report less recent sexual intercourse (>30 days from survey enumeration) are largely excluded from global health monitoring and evaluation efforts. This study investigated level and contextual factors in modern contraceptive ut...

Now Is the Time to Safeguard Access to Emergency Contraception Before Abortion Restrict...
https://doi.org/10.1016/j.contraception.2022.06.008
Contraception Cleland K, Kumar B et. al.

Jun 27th, 2022 - Abortion and contraception are essential components of reproductive healthcare. As 26 states are likely to severely restrict access to abortion following the Supreme Court decision in Dobbs v. Jackson Women's Health Organization, access to emergen...

Reducing Adolescent Pregnancy in the Emergency Department
https://clinicaltrials.gov/ct2/show/NCT04744155

Jun 14th, 2022 - Unintended adolescent pregnancy is a major public health problem linked to pregnancy-induced hypertension, low birthweight, and prematurity. In addition, adolescent pregnancies cost an estimated $9.4 billion annually. Though declining, U.S. rates ...

Ulipristal Acetate for Use in Early Pregnancy Loss
https://clinicaltrials.gov/ct2/show/NCT05216952

Jun 10th, 2022 - Study Background: Early pregnancy loss affects approximately 10% of women throughout their reproductive lives and many women desire medical management of early pregnancy loss. Data from two large randomized controlled trials suggests that pretreat...

Double morning-after pill dose for women with obesity not effective
https://www.mdedge.com/obgyn/article/255336/contraception/double-morning-after-pill-dose-women-obesity-not-effective
Marcia Frellick

Jun 9th, 2022 - Emergency contraception is more likely to fail in women with obesity, but simply doubling the dose of levonorgestrel (LNG)-based contraception does not appear to be effective according to the results of a randomized, controlled trial. Alison B.

see more →

Guidelines  8 results

ACOG Practice Bulletin No. 206 Summary: Use of Hormonal Contraception in Women With Coe...
https://doi.org/10.1097/AOG.0000000000003073
Obstetrics and Gynecology;

Jan 27th, 2019 - Although numerous studies have addressed the safety and effectiveness of hormonal contraceptive use in healthy women, data regarding women with underlying medical conditions or other special circumstances are limited. The U.S. Medical Eligibility ...

ACOG Practice Bulletin No. 206: Use of Hormonal Contraception in Women With Coexisting ...
https://doi.org/10.1097/AOG.0000000000003072
Obstetrics and Gynecology;

Jan 27th, 2019 - Although numerous studies have addressed the safety and effectiveness of hormonal contraceptive use in healthy women, data regarding women with underlying medical conditions or other special circumstances are limited. The U.S. Medical Eligibility ...

Committee Opinion No 707: Access to Emergency Contraception.
https://doi.org/10.1097/AOG.0000000000002162
Obstetrics and Gynecology;

Jun 24th, 2017 - Emergency contraception refers to contraceptive methods used to prevent pregnancy in the first few days after unprotected intercourse, sexual assault, or contraceptive failure. Although the U.S. Food and Drug Administration approved the first dedi...

Canadian Contraception Consensus (Part 2 of 4).
https://www.ncbi.nlm.nih.gov/pubmed/26629725
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Black A, Guilbert E et. al.

Dec 3rd, 2015 - To provide guidelines for health care providers on the use of contraceptive methods to prevent pregnancy and on the promotion of healthy sexuality. Guidance for Canadian practitioners on overall effectiveness, mechanism of action, indications, con...

Emergency contraception: no. 280 (replaces No. 131, August 2003).
https://doi.org/10.1016/j.ijgo.2012.09.006
International Journal of Gynaecology and Obstetrics: the ... Dunn S, Guilbert É et. al.

Feb 8th, 2013 - To review current knowledge about emergency contraception (EC), including available options, their modes of action, efficacy, safety, and the effective provision of EC within a practice setting. The combined estradiol-levonorgestrel (Yuzpe regimen...

see more →

Drugs  69 results see all →

Clinicaltrials.gov  57 results

Reducing Adolescent Pregnancy in the Emergency Department
https://clinicaltrials.gov/ct2/show/NCT04744155

Jun 14th, 2022 - Unintended adolescent pregnancy is a major public health problem linked to pregnancy-induced hypertension, low birthweight, and prematurity. In addition, adolescent pregnancies cost an estimated $9.4 billion annually. Though declining, U.S. rates ...

Ulipristal Acetate for Use in Early Pregnancy Loss
https://clinicaltrials.gov/ct2/show/NCT05216952

Jun 10th, 2022 - Study Background: Early pregnancy loss affects approximately 10% of women throughout their reproductive lives and many women desire medical management of early pregnancy loss. Data from two large randomized controlled trials suggests that pretreat...

Piroxicam and Levonorgestrel Co-treatment for Emergency Contraception
https://clinicaltrials.gov/ct2/show/NCT03614494

May 17th, 2022 - Objective: To compare the percentage of pregnancies prevented by LNG co-administered with piroxicam or placebo for oral emergency contraception (EC) by a randomised controlled trial. Hypothesis to be tested: LNG plus piroxicam has higher percentag...

Quick Start of Highly Effective Contraception
https://clinicaltrials.gov/ct2/show/NCT02076217

May 6th, 2022 - Women seeking emergency contraception (EC) frequently report multiple recent episodes of unprotected sex. Although high sensitivity urine pregnancy tests effectively rule-out pregnancy resulting from sex that occurred more than 14 days ago, clinic...

Safety and Efficacy of CDB-2914 in Comparison to Levonorgestrel for Emergency Contraception
https://clinicaltrials.gov/ct2/show/NCT00551616

May 3rd, 2022 - The purpose of this study is to assess the safety and efficacy of CDB-2914 in comparison to levonorgestrel for preventing pregnancy up to 5 days after unprotected sexual intercourse.

see more →

News  204 results

Double morning-after pill dose for women with obesity not effective
https://www.mdedge.com/obgyn/article/255336/contraception/double-morning-after-pill-dose-women-obesity-not-effective
Marcia Frellick

Jun 9th, 2022 - Emergency contraception is more likely to fail in women with obesity, but simply doubling the dose of levonorgestrel (LNG)-based contraception does not appear to be effective according to the results of a randomized, controlled trial. Alison B.

Oklahoma Gov. Signs Bill That Bans Nearly All Abortions
https://www.medscape.com/viewarticle/974690

May 26th, 2022 - Oklahoma Gov. Kevin Stitt signed a bill into law on Wednesday that bans almost all abortions in the state, starting at fertilization. The new law is the most restrictive abortion ban in the U.S., making exceptions only when an abortion is necessar...

Contraceptive use boosted by enhanced counseling
https://www.mdedge.com/obgyn/article/254855/contraception/contraceptive-use-boosted-enhanced-counseling
Heidi Splete

May 23rd, 2022 - Contraceptive counseling and interventions beyond usual care significantly increased the use of contraceptives with no accompanying increase in sexually transmitted infections or reduction in condom use, based on data from a new meta-analysis. “Al.

Oklahoma Lawmakers Pass Near-Total Abortion Ban
https://www.medscape.com/viewarticle/974312

May 20th, 2022 - (Reuters) - Oklahoma lawmakers on Thursday gave final approval to a bill that would ban nearly all abortions and would allow private citizens to sue anyone who helps women terminate a pregnancy. The bill would take effect immediately upon being si...

ACOG Drops 2023 New Orleans Meeting Over Abortion Concerns
https://www.medscape.com/viewarticle/974293

May 19th, 2022 - The American College of Obstetricians and Gynecologists (ACOG) has scrapped a plan to hold its 2023 annual clinical and scientific meeting in New Orleans, saying it cannot convene in a place where its members might face punishment for providing or...

see more →